[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Approvals - February 2005

  ANDA Number Generic Drug Name Applicant Approval Date
1 77-039 CITALOPRAM HYDROBROMIDE TABLETS 10 MG (BASE), 20 MG (BASE), AND 40 MG (BASE)   MYLAN PHARMACEUTICALS, INC. 2/3/2005 
2 65-205 AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP, (CHEWABLE 200 MG/28.5 MG (BASE) AND 400 MG/57 MG (BASE)   TEVA PHARMACEUTICALS USA 2/9/2005 
3 77-155 FENOLDOPAM MESYLATE INJECTION, USP 10 MG (BASE)/ML; PACKAGED IN 10 MG (BASE)/1 ML AND 20 MG (BASE)/2 ML SINGLE-DOSE AMPULES   SABEX 2002 INC. 2/15/2005 
4 40-547 METHIMAZOLE TABLETS, USP 5 MG, 10 MG, AND 20 MG   CEDAR PHARMACEUTICALS LLC 2/18/2005 
5 76-712 TERCONAZOLE VAGINAL CREAM 0.4%   ALTANA INC. 2/18/2005 
6 40-557 METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION, USP 40 MG/ML AND 80 MG/ML   SICOR PHARMACEUTICALS, INC. 2/23/2005 
7 40-586 PRIMIDONE TABLETS, USP 50 MG AND 250 MG   VINTAGE PHARMACEUTICALS, LLC 2/24/2005 
8 40-607 ACETIC ACID OTIC SOLUTION, USP 2%   VINTAGE PHARMACEUTICALS, LLC 2/24/2005 
9 65-152 CEPHALEXIN CAPSULES, USP 250 MG AND 500 MG   YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO., 2/24/2005 

Back to Top      Back to Approvals

Date created: March 5, 2005

horizonal rule